1. Management of Idiopathic Macular Telangiectasia Type 2

   • Alireza Khodabande
   • Ramak Roohipoor
   • Bobeck S. Modjtahedi

   Review Open access 20 February 2019 Pages: 155 - 175

   

2. Reviewing the Pathophysiology Behind the Advances in the Management of Giant Cell Arteritis

   • Alia Z. Al-Mousawi
   • Sam P. Gurney
   • Susan P. Mollan

   Review Open access 01 March 2019 Pages: 177 - 193

   

3. A Review of Corneal Endotheliitis and Endotheliopathy: Differential Diagnosis, Evaluation, and Treatment

   • Majid Moshirfar
   • Michael S. Murri
   • Phillip C. Hoopes

   Review Open access 11 March 2019 Pages: 195 - 213

   

4. Pearls and Pitfalls of Optical Coherence Tomography Angiography Imaging: A Review

   • Enrico Borrelli
   • SriniVas R. Sadda
   • Giuseppe Querques

   Review Open access 13 March 2019 Pages: 215 - 226

   

5. Ocular Manifestations of Granulomatosis with Polyangiitis: A Review of the Literature

   • Evdokia Sfiniadaki
   • Ioanna Tsiara
   • Irini Chatziralli

   Review Open access 15 March 2019 Pages: 227 - 234

6. Macular Atrophy of the Retinal Pigment Epithelium in Patients with Neovascular Age-Related Macular Degeneration: What is the Link? Part I: A Review of Disease Characterization and Morphological Associations

   • Mania Horani
   • Sajjad Mahmood
   • Tariq M. Aslam

   Review Open access 25 March 2019 Pages: 235 - 249

7. Adherence to Treatment and Follow-Up in Patients with Severe Chemical Eye Burns

   • Mukhtar Bizrah
   • Ammar Yusuf
   • Sajjad Ahmad

   Original Research Open access 13 March 2019 Pages: 251 - 259

   

8. Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification

   • Melissa M. Toyos

   Original Research Open access 13 March 2019 Pages: 261 - 270

   

9. Effect of Solution pH on Distribution of Ophthalmically Administered Brimonidine in Posterior Ocular Tissues in Pigmented Rabbits

   • Keisuke Shinno
   • Kazuya Kurokawa
   • Hideki Tokushige

   Original Research Open access 20 March 2019 Pages: 271 - 277

   

10. Short-Term Safety Evaluation of a Multi-Pressure Dial: A Prospective, Open-label, Non-randomized Study

    • Vance M. Thompson
    • Tanner J. Ferguson
    • John P. Berdahl

    Original Research Open access 27 March 2019 Pages: 279 - 287

    

11. Real-Life Evidence for Using a Treat-and-Extend Injection Regime for Patients with Central Retinal Vein Occlusion

    • Maria Eleftheriadou
    • Luke Nicholson
    • Peter K. F. Addison

    Original Research Open access 10 April 2019 Pages: 289 - 296

    

12. Outcomes after Epiretinal Membrane Surgery with or Without Internal Limiting Membrane Peeling

    • Josef Guber
    • Ioana Pereni
    • Richard J. Haynes

    Original Research Open access 19 April 2019 Pages: 297 - 303

    

13. Expediency of the Automated Perimetry Using the Goldmann V Stimulus Size in Visually Impaired Patients with Glaucoma

    • Adriana M. Morgan
    • Livia S. Mazzoli
    • Niro Kasahara

    Brief Report Open access 13 March 2019 Pages: 305 - 311

    

14. Efficacy and Safety of Wet Wipes Containing Hy-Ter^® Solution Compared with Standard Care for Bilateral Posterior Blepharitis: A Preliminary Randomized Controlled Study

    • Valentina De Luca
    • Adriano Carnevali
    • Vincenzo Scorcia

    Brief Report Open access 30 March 2019 Pages: 313 - 321

    

15. Trabeculectomy with Suprachoroidal Derivation in Eyes with Uncontrolled Glaucoma: A Case Series with a 24-Month Follow-up

    • Rodolfo A. Perez-Grossmann
    • Daniel E. Grigera
    • Alan Wenger

    Case Series Open access 16 March 2019 Pages: 323 - 331

    

16. Nd:YAG Laser for Ahmed Tube Shunt Blockage in Patients Implanted with Boston Type I Keratoprosthesis

    • Jianjun Gu
    • Yuying Zhang
    • Jiaqi Chen

    Case Series Open access 29 April 2019 Pages: 333 - 339

    

17. Opacification of Akreos Hydrophilic Acrylic Lens After Retinal Detachment Repair with Silicone Oil Tamponade: A Case Report

    • Ninel Z. Gregori
    • Jose J. Echegaray
    • Harry W. Flynn Jr.

    Case Report Open access 28 March 2019 Pages: 341 - 345

    

18. Correction to: In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits

    • John D. Sheppard
    • Paul C. Cockrum
    • Mark C. Jasek

    Correction Open access 19 February 2019 Pages: 347 - 348